{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:21:16Z","timestamp":1773418876500,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","award":["PPA-0517\u20130717-RAD"],"award-info":[{"award-number":["PPA-0517\u20130717-RAD"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","award":["TA-GT-0521-0799-RAD-TRAP"],"award-info":[{"award-number":["TA-GT-0521-0799-RAD-TRAP"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002089","name":"Fight for Sight","doi-asserted-by":"publisher","award":["5053\/50584"],"award-info":[{"award-number":["5053\/50584"]}],"id":[{"id":"10.13039\/100002089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["205041"],"award-info":[{"award-number":["205041"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["813490"],"award-info":[{"award-number":["813490"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ymthe.2024.01.019","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T03:04:29Z","timestamp":1705806269000},"page":"837-851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Proof-of-concept for multiple AON delivery by a single U7snRNA vector to restore splicing defects in ABCA4"],"prefix":"10.1016","volume":"32","author":[{"given":"Nuria","family":"Su\u00e1rez-Herrera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris B.","family":"Riswick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"V\u00e1zquez-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lonneke","family":"Duijkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dyah W.","family":"Karjosukarso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Bauwens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elfride","family":"De Baere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Cheetham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Garanto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4347-6503","authenticated-orcid":false,"given":"Rob W.J.","family":"Collin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.01.019_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/ceo.13917","article-title":"Inherited retinal diseases: Therapeutics, clinical trials and end points-A review","volume":"49","author":"Georgiou","year":"2021","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.01.019_bib2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028274","article-title":"Photoreceptor Cilia and Retinal Ciliopathies","volume":"9","author":"Bujakowska","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ymthe.2024.01.019_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/genes8110304","article-title":"Target 5000: Target Capture Sequencing for Inherited Retinal Degenerations","volume":"8","author":"Dockery","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymthe.2024.01.019_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/bjophthalmol-2016-308823","article-title":"Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options","volume":"101","author":"Tanna","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.01.019_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100861","article-title":"Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations","volume":"79","author":"Cremers","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2024.01.019_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4419-5635-4_8","article-title":"The ATP-binding cassette transporter ABCA4: structural and functional properties and role in retinal disease","volume":"703","author":"Tsybovsky","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymthe.2024.01.019_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/bs.pmbts.2015.06.008","article-title":"Insights into the Molecular Properties of ABCA4 and Its Role in the Visual Cycle and Stargardt Disease","volume":"134","author":"Molday","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.ymthe.2024.01.019_bib8","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1093\/hmg\/ddu396","article-title":"Analysis of the ABCA4 genomic locus in Stargardt disease","volume":"23","author":"Zernant","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2024.01.019_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajhg.2016.12.003","article-title":"Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal Disease","volume":"100","author":"Carss","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2024.01.019_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1101\/gr.226621.117","article-title":"ABCA4 midigenes reveal the full splice spectrum of all reported noncanonical splice site variants in Stargardt disease","volume":"28","author":"Sangermano","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.ymthe.2024.01.019_bib11","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41436-018-0420-y","article-title":"ABCA4-associated disease as a model for missing heritability in autosomal recessive disorders: novel noncoding splice, cis-regulatory, structural, and recurrent hypomorphic variants","volume":"21","author":"Bauwens","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2024.01.019_bib12","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41436-018-0414-9","article-title":"Deep-intronic ABCA4 variants explain missing heritability in Stargardt disease and allow correction of splice defects by antisense oligonucleotides","volume":"21","author":"Sangermano","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2024.01.019_bib13","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/humu.23890","article-title":"Identification of splice defects due to noncanonical splice site or deep-intronic variants in ABCA4","volume":"40","author":"Fadaie","year":"2019","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymthe.2024.01.019_bib14","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41436-020-0787-4","article-title":"Resolving the dark matter of ABCA4 for 1054 Stargardt disease probands through integrated genomics and transcriptomics","volume":"22","author":"Khan","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2024.01.019_bib15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.omtn.2020.06.007","article-title":"Detailed Phenotyping and Therapeutic Strategies for Intronic ABCA4 Variants in Stargardt Disease","volume":"21","author":"Khan","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2024.01.019_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/iovs.63.2.11","article-title":"Impact of Next Generation Sequencing in Unraveling the Genetics of 1036 Spanish Families With Inherited Macular Dystrophies","volume":"63","author":"Del Pozo-Valero","year":"2022","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2024.01.019_bib17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ajhg.2018.02.008","article-title":"Identification and Rescue of Splice Defects Caused by Two Neighboring Deep-Intronic ABCA4 Mutations Underlying Stargardt Disease","volume":"102","author":"Albert","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2024.01.019_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/genes10090654","article-title":"Molecular Therapies for Inherited Retinal Diseases-Current Standing, Opportunities and Challenges","volume":"10","author":"V\u00e1zquez-Dom\u00ednguez","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymthe.2024.01.019_bib19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/ICU.0000000000000363","article-title":"Applications of antisense oligonucleotides for the treatment of inherited retinal diseases","volume":"28","author":"Collin","year":"2017","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.01.019_bib20","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1093\/nar\/gkw533","article-title":"Splice-switching antisense oligonucleotides as therapeutic drugs","volume":"44","author":"Havens","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2024.01.019_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.tig.2011.02.004","article-title":"Genetic therapies for RNA mis-splicing diseases","volume":"27","author":"Hammond","year":"2011","journal-title":"Trends Genet."},{"key":"10.1016\/j.ymthe.2024.01.019_bib22","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013243","article-title":"Delivery of oligonucleotide-based therapeutics: challenges and opportunities","volume":"13","author":"Hammond","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2024.01.019_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cells11243947","article-title":"Correction of the Splicing Defect Caused by a Recurrent Variant in ABCA4 (c.769-784C>T) That Underlies Stargardt Disease","volume":"11","author":"Tomkiewicz","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2024.01.019_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094621","article-title":"Antisense Oligonucleotide-Based Rescue of Aberrant Splicing Defects Caused by 15 Pathogenic Variants in ABCA4","volume":"22","author":"Tomkiewicz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.01.019_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/genes10060452","article-title":"Antisense Oligonucleotide Screening to Optimize the Rescue of the Splicing Defect Caused by the Recurrent Deep-Intronic ABCA4 Variant c.4539+2001G>A in Stargardt Disease","volume":"10","author":"Garanto","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymthe.2024.01.019_bib26","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/mt.2012.26","article-title":"Engineering multiple U7snRNA constructs to induce single and multiexon-skipping for Duchenne muscular dystrophy","volume":"20","author":"Goyenvalle","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.01.019_bib27","series-title":"Exon Skipping: Methods and Protocols","first-page":"259","article-title":"Engineering U7snRNA Gene to Reframe Transcripts","author":"Goyenvalle","year":"2012"},{"key":"10.1016\/j.ymthe.2024.01.019_bib28","first-page":"2552","article-title":"In\u00a0vitro and in\u00a0vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery","volume":"25","author":"Garanto","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2024.01.019_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3321","article-title":"U7 snRNA: A tool for gene therapy","volume":"23","author":"Gadgil","year":"2021","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.ymthe.2024.01.019_bib30","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1007\/s00018-004-4190-0","article-title":"The special Sm core structure of the U7 snRNP: far-reaching significance of a small nuclear ribonucleoprotein","volume":"61","author":"Sch\u00fcmperli","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2024.01.019_bib31","first-page":"1317","article-title":"U7 snRNA, a Small RNA with a Big Impact in Gene Therapy","volume":"32","author":"Lesman","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.01.019_bib32","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.1870","article-title":"Differentiation of Human Embryonic Stem Cells into Cone Photoreceptors","volume":"6","author":"Flamier","year":"2016","journal-title":"Bio-protocol"},{"key":"10.1016\/j.ymthe.2024.01.019_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13816810.2021.1966053","article-title":"Stargardt disease and progress in therapeutic strategies","volume":"43","author":"Huang","year":"2022","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.ymthe.2024.01.019_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073563","article-title":"Defining Phenotype, Tropism, and Retinal Gene Therapy Using Adeno-Associated Viral Vectors (AAVs) in New-Born Brown Norway Rats with a Spontaneous Mutation in Crb1","volume":"22","author":"Boon","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.01.019_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7281912","article-title":"Comparative AAV-eGFP Transgene Expression Using Vector Serotypes 1-9, 7m8, and 8b in Human Pluripotent Stem Cells, RPEs, and Human and Rat Cortical Neurons","volume":"2019","author":"Duong","year":"2019","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.ymthe.2024.01.019_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coviro.2016.08.003","article-title":"In\u00a0vivo tissue-tropism of adeno-associated viral vectors","volume":"21","author":"Srivastava","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ymthe.2024.01.019_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2015.07.006","article-title":"Adeno-associated virus serotypes for gene therapeutics","volume":"24","author":"Lisowski","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ymthe.2024.01.019_bib38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1248\/bpb.b18-00913","article-title":"Adeno Associated Virus (AAV) as a Tool for Clinical and Experimental Delivery of Target Genes into the Mammalian Retina","volume":"42","author":"Hori","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ymthe.2024.01.019_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mt.2009.255","article-title":"Effect of genome size on AAV vector packaging","volume":"18","author":"Wu","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.01.019_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.visres.2007.07.027","article-title":"Versatility of AAV vectors for retinal gene transfer","volume":"48","author":"Surace","year":"2008","journal-title":"Vis. Res."},{"key":"10.1016\/j.ymthe.2024.01.019_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/v11020102","article-title":"Adeno-associated Virus (AAV) versus Immune Response","volume":"11","author":"Rabinowitz","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2024.01.019_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1167\/tvst.9.7.20","article-title":"Assessment of AAV Dual Vector Safety in theAbca4(-\/-) Mouse Model of Stargardt Disease","volume":"9","author":"McClements","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.ymthe.2024.01.019_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","article-title":"Emerging Issues in AAV-Mediated In\u00a0Vivo Gene Therapy","volume":"8","author":"Colella","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.01.019_bib44","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2024.01.019_bib45","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ymthe.2020.11.029","article-title":"Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy","volume":"29","author":"Maguire","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.01.019_bib46","article-title":"RNA-based therapies in inherited retinal diseases","volume":"14","author":"Girach","year":"2022","journal-title":"Ther. Adv. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.01.019_bib47","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.stemcr.2021.08.008","article-title":"Human stem cell-based retina on chip as new translational model for validation of AAV retinal gene therapy vectors","volume":"16","author":"Achberger","year":"2021","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ymthe.2024.01.019_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030994","article-title":"AAV-Mediated Gene Delivery to 3D Retinal Organoids Derived from Human Induced Pluripotent Stem Cells","volume":"21","author":"Garita-Hernandez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.01.019_bib49","first-page":"1616","article-title":"Spatiotemporal Expression Patterns of N-Syndecan, a Transmembrane Heparan Sulfate Proteoglycan Developing Retina","volume":"43","author":"Inatani","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2024.01.019_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101118","article-title":"Heparan sulfate proteoglycans (HSPGs) of the ocular lens","volume":"93","author":"Wishart","year":"2023","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2024.01.019_bib51","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1007\/s00018-021-03917-4","article-title":"A look into retinal organoids: methods, analytical techniques, and applications","volume":"78","author":"Afanasyeva","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2024.01.019_bib52","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/s41591-018-0185-5","article-title":"Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia","volume":"24","author":"Xue","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.01.019_bib53","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","article-title":"Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial","volume":"383","author":"MacLaren","year":"2014","journal-title":"The Lancet"},{"key":"10.1016\/j.ymthe.2024.01.019_bib54","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41591-020-0763-1","article-title":"Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR","volume":"26","author":"Cehajic-Kapetanovic","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.01.019_bib55","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-term effect of gene therapy on Leber's congenital amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.01.019_bib56","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fimmu.2016.00037","article-title":"Ocular Immune Privilege and Transplantation","volume":"7","author":"Taylor","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.01.019_bib57","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fimmu.2012.00296","article-title":"The privileged immunity of immune privileged organs: the case of the eye","volume":"3","author":"Benhar","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.01.019_bib58","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.omtm.2021.05.011","article-title":"Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina","volume":"22","author":"Chandler","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.01.019_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd3438","article-title":"Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses","volume":"13","author":"Chan","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.01.019_bib60","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.xphs.2021.03.024","article-title":"Manufacturing Challenges and Rational Formulation Development for AAV Viral Vectors","volume":"110","author":"Srivastava","year":"2021","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ymthe.2024.01.019_bib61","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.omtm.2020.07.007","article-title":"AAV-Genome Population Sequencing of Vectors Packaging CRISPR Components Reveals Design-Influenced Heterogeneity","volume":"18","author":"Tran","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.01.019_bib62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-61779-767-5_17","article-title":"Engineering U7snRNA gene to reframe transcripts","volume":"867","author":"Goyenvalle","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2024.01.019_bib63","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-0716-2010-6_9","article-title":"Development and Use of Cellular Systems to Assess and Correct Splicing Defects","volume":"2434","author":"Su\u00e1rez-Herrera","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2024.01.019_bib64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/iovs.63.5.27","article-title":"Identification of a Complex Allele in IMPG2 as a Cause of Adult-Onset Vitelliform Macular Dystrophy","volume":"63","author":"V\u00e1zquez-Dom\u00ednguez","year":"2022","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2024.01.019_bib65","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s13287-020-01883-5","article-title":"COCO enhances the efficiency of photoreceptor precursor differentiation in early human embryonic stem cell-derived retinal organoids","volume":"11","author":"Pan","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ymthe.2024.01.019_bib66","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1242\/dev.125385","article-title":"Differentiation of human embryonic stem cells into cone photoreceptors through simultaneous inhibition of BMP, TGFbeta and Wnt signaling","volume":"142","author":"Zhou","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.ymthe.2024.01.019_bib67","article-title":"Precipitation of RNA with Ethanol","volume":"2020","author":"Green","year":"2020","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.ymthe.2024.01.019_bib68","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2212\u0394\u0394CT Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ymthe.2024.01.019_bib69","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624000194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624000194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:12:36Z","timestamp":1761502356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624000194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1525001624000194"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.01.019","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proof-of-concept for multiple AON delivery by a single U7snRNA vector to restore splicing defects in ABCA4","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024","name":"copyright","label":"Copyright"}]}}